4.5 Article

Fasting time and lipid parameters: association with hepatic steatosis - data from a random population sample

期刊

LIPIDS IN HEALTH AND DISEASE
卷 13, 期 -, 页码 -

出版社

BMC
DOI: 10.1186/1476-511X-13-18

关键词

Lipids; Total cholesterol; LDL cholesterol; HDL cholesterol; Triglycerides; Fasting time; Population-based; Cross-sectional; Non-alcoholic fatty liver disease (NAFLD)

资金

  1. government of the state of Baden-Wurttemberg, Germany
  2. Baden-Wurttemberg State Health Office of the District Government of Stuttgart, Germany
  3. administration of the City of Leutkirch, Germany

向作者/读者索取更多资源

Background: Current guidelines recommend measuring plasma lipids in fasting patients. Recent studies, however, suggest that variation in plasma lipid concentrations secondary to fasting time may be minimal. Objective of the present study was to investigate the impact of fasting time on plasma lipid concentrations (total cholesterol, HDL and LDL cholesterol, triglycerides). A second objective was to determine the effect of non-alcoholic fatty liver disease exerted on the above-mentioned lipid levels. Method: Subjects participating in a population-based cross-sectional study (2,445 subjects; 51.7% females) were questioned at time of phlebotomy regarding duration of pre-phlebotomy fasting. Total cholesterol, LDL and HDL cholesterol, and triglycerides were determined and correlated with length of fasting. An upper abdominal ultrasonographic examination was performed and body-mass index (BMI) and waist-to-hip ratio (WHR) were calculated. Subjects were divided into three groups based on their reported fasting periods of 1-4 h, 4-8 h and > 8 h. After application of the exclusion criteria, a total of 1,195 subjects (52.4% females) were included in the study collective. The Kruskal-Wallis test was used for continuous variables and the chi-square test for categorical variables. The effects of age, BMI, WHR, alcohol consumption, fasting time and hepatic steatosis on the respective lipid variables were analyzed using multivariate logistic regression. Results: At multivariate analysis, fasting time was associated with elevated triglycerides (p = 0.0047 for 1-4 h and p = 0.0147 for 4-8 h among females; p < 0.0001 for 1-4 h and p= 0.0002 for 4-8 h among males) and reduced LDL cholesterol levels (p = 0.0003 for 1-4 h and p= 0.0327 for 4-8 h among males). Among males, hepatic steatosis represents an independent factor affecting elevated total cholesterol (p = 0.0278) and triglyceride concentrations (p = 0.0002). Conclusion: Total and HDL cholesterol concentrations are subject to slight variations in relation to the duration of the pre-phlebotomy fasting period. LDL cholesterol and triglycerides exhibit highly significant variability; the greatest impact is seen with the triglycerides. Fasting time represents an independent factor for reduced LDL cholesterol and elevated triglyceride concentrations. There is a close association between elevated lipids and hepatic steatosis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cardiac & Cardiovascular Systems

Ethnic comparison in takotsubo syndrome: novel insights from the International Takotsubo Registry

Yoichi Imori, Ken Kato, Victoria L. Cammann, Konrad A. Szawan, Manfred Wischnewsky, Sara Dreiding, Michael Wuerdinger, Maximilian Schoenberger, Vanya Petkova, David Niederseer, Rena A. Levinson, Davide Di Vece, Sebastiano Gili, Burkhardt Seifert, Masaki Wakita, Noriko Suzuki, Rodolfo Citro, Eduardo Bossone, Susanne Heiner, Maike Knorr, Thomas Jansen, Thomas Muenzel, Fabrizio D'Ascenzo, Jennifer Franke, Ioana Sorici-Barb, Hugo A. Katus, Annahita Sarcon, Jerold Shinbane, L. Christian Napp, Johann Bauersachs, Milosz Jaguszewski, Reiko Shiomura, Shunichi Nakamura, Hitoshi Takano, Michel Noutsias, Christof Burgdorf, Iwao Ishibashi, Toshiharu Himi, Wolfgang Koenig, Heribert Schunkert, Holger Thiele, Behrouz Kherad, Carsten Tschope, Burkert M. Pieske, Lawrence Rajan, Guido Michels, Roman Pfister, Shingo Mizuno, Alessandro Cuneo, Claudius Jacobshagen, Gerd Hasenfuss, Mahir Karakas, Hiroki Mochizuki, Alexander Pott, Wolfgang Rottbauer, Samir M. Said, Ruediger C. Braun-Dullaeus, Adrian Banning, Toshiaki Isogai, Akihisa Kimura, Florim Cuculi, Richard Kobza, Thomas A. Fischer, Tuija Vasankari, K. E. Juhani Airaksinen, Yasuhiro Tomita, Monika Budnik, Grzegorz Opolski, Rafal Dworakowski, Philip MacCarthy, Christoph Kaiser, Stefan Osswald, Leonarda Galiuto, Filippo Crea, Wolfgang Dichtl, Tsutomu Murakami, Yuji Ikari, Klaus Empen, Daniel Beug, Stephan B. Felix, Clement Delmas, Olivier Lairez, Tetsuo Yamaguchi, Ibrahim El-Battrawy, Ibrahim Akin, Martin Borggrefe, John D. Horowitz, Martin Kozel, Petr Tousek, Petr Widimsky, Ekaterina Gilyarova, Alexandra Shilova, Mikhail Gilyarov, Michael Neuhaus, Philippe Meyer, Jose David Arroja, Christina Chan, Paul Bridgman, Jan Galuszka, Gregor Poglajen, Pedro Carrilho-Ferreira, Fausto J. Pinto, Christian Hauck, Lars S. Maier, Kan Liu, Carlo Di Mario, Carla Paolini, Claudio Bilato, Matteo Bianco, Lucas Joerg, Hans Rickli, David E. Winchester, Christian Ukena, Michael Boehm, Jeroen J. Bax, Abhiram Prasad, Charanjit S. Rihal, Shigeru Saito, Yoshio Kobayashi, Thomas F. Luscher, Frank Ruschitzka, Wataru Shimizu, Jelena R. Ghadri, Christian Templin

Summary: This study compared clinical characteristics and in-hospital outcomes between Japanese and European takotsubo syndrome (TTS) patients, revealing differences in triggers and outcomes between the two ethnic groups. Despite worse in-hospital outcomes for Japanese patients, ethnicity itself does not appear to impact TTS patient outcomes. Machine learning analysis identified physical stressors as the most important prognostic factor for both Japanese and European TTS patients.

CLINICAL RESEARCH IN CARDIOLOGY (2022)

Article Biochemistry & Molecular Biology

Association of serum uromodulin with adipokines in dependence of type 2 diabetes

Cornelia Then, Christian Herder, Barbara Thorand, Chaterina Sujana, Margit Heier, Christa Meisinger, Annette Peters, Wolfgang Koenig, Wolfgang Rathmann, Michael Roden, Michael Stumvoll, Haifa Maalmi, Holger Then, Uta Ferrari, Juergen Scherberich, Jochen Seissler

Summary: This study found that serum uromodulin is inversely associated with pro-inflammatory adipokines chemerin and retinol-binding protein-4. The association is stronger in participants with type 2 diabetes, but the association of uromodulin with type 2 diabetes is independent of chemerin and retinol-binding protein-4.

CYTOKINE (2022)

Article Cardiac & Cardiovascular Systems

Associations of the vasoactive peptides CT-proET-1 and MR-proADM with incident type 2 diabetes: results from the BiomarCaRE Consortium

Chaterina Sujana, Veikko Salomaa, Frank Kee, Jochen Seissler, Pekka Jousilahti, Charlotte Neville, Cornelia Then, Wolfgang Koenig, Kari Kuulasmaa, Jaakko Reinikainen, Stefan Blankenberg, Tanja Zeller, Christian Herder, Ulrich Mansmann, Annette Peters, Barbara Thorand

Summary: The study found that higher concentrations of CT-proET-1 and MR-proADM are associated with incident type 2 diabetes, especially in obese individuals. Mendelian randomisation analysis suggests a probable causal link for CT-proET-1.

CARDIOVASCULAR DIABETOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial

Jean Claude Tardif, Marc A. Pfeffer, Simon Kouz, Wolfgang Koenig, Aldo P. Maggioni, John J. McMurray, Vincent Mooser, David D. Waters, Jean C. Gregoire, Philippe L. L'Allier, J. Wouter Jukema, Harvey D. White, Therese Heinonen, Donald M. Black, Fouzia Laghrissi-Thode, Sylvie Levesque, Marie Claude Guertin, Marie Pierre Dube, Dal-GenE Investigators

Summary: The dal-GenE study aimed to test the pharmacogenetic hypothesis that the effect of dalcetrapib on cardiovascular events is influenced by an ADCY9 gene polymorphism. However, the study found that dalcetrapib did not significantly reduce the risk of occurrence of ischemic cardiovascular events. Further trials are needed to investigate the effect of dalcetrapib on patients with the AA genotype.

EUROPEAN HEART JOURNAL (2022)

Article Transplantation

Association between the fatty liver index and chronic kidney disease: the population-based KORA study

Xinting Cai, Barbara Thorand, Simon Hohenester, Wolfgang Koenig, Wolfgang Rathmann, Annette Peters, Jana Nano

Summary: This German cohort study aimed to evaluate the relationship between fatty liver and kidney function/chronic kidney disease (CKD). The study found that fatty liver is associated with kidney function and CKD, and this association is partially mediated by metabolic factors such as inflammation, diabetes, and hypertension.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Review Cardiac & Cardiovascular Systems

PCSK9 Inhibitor Wars: How Does Inclisiran Fit in with Current Monoclonal Antibody Inhibitor Therapy? Considerations for Patient Selection

Natalie Arnold, Wolfgang Koenig

Summary: This review critically summarizes the emerging cholesterol-lowering therapy targeting PCSK9, with a focus on the use of anti-PCSK9 monoclonal antibodies (mAbs) and inclisiran. Although both drug classes show similar efficacy in reducing LDL-C levels, the long-term safety and CV outcomes of inclisiran are still unknown.

CURRENT CARDIOLOGY REPORTS (2022)

Article Cardiac & Cardiovascular Systems

Efficacy and Safety of Inclisiran in Patients with Polyvascular Disease: Pooled, Post Hoc Analysis of the ORION-9, ORION-10, and ORION-11 Phase 3 Randomized Controlled Trials

Wolfgang Koenig, Lorena Garcia Conde, Ulf Landmesser, Lawrence A. Leiter, Kausik K. Ray, Gregory G. Schwartz, R. Scott Wright, Jackie Han, Frederick J. Raal

Summary: This study analyzed the lipid-lowering efficacy and safety of inclisiran versus placebo in patients with and without polyvascular disease (PVD). The results showed that twice-yearly inclisiran dosing effectively reduced LDL-C levels and was well tolerated in patients, irrespective of PVD status.

CARDIOVASCULAR DRUGS AND THERAPY (2022)

Article Cardiac & Cardiovascular Systems

Exploring the incremental utility of circulating biomarkers for robust risk prediction of incident atrial fibrillation in European cohorts using regressions and modern machine learning methods

Betul Toprak, Stephanie Brandt, Jan Brederecke, Francesco Gianfagna, Julie K. K. Vishram-Nielsen, Francisco M. Ojeda, Simona Costanzo, Christin S. Borschel, Stefan Soderberg, Ioannis Katsoularis, Stephan Camen, Erkki Vartiainen, Maria Benedetta Donati, Jukka Kontto, Martin Bobak, Ellisiv B. Mathiesen, Allan Linneberg, Wolfgang Koenig, Maja-Lisa Lochen, Augusto Di Castelnuovo, Stefan Blankenberg, Giovanni de Gaetano, Kari Kuulasmaa, Veikko Salomaa, Licia Iacoviello, Teemu Niiranen, Tanja Zeller, Renate B. Schnabel

Summary: The study aims to find reliable circulating predictors for incident atrial fibrillation (AF) using classical regressions and machine learning techniques. Fourteen routinely available biomarkers reflecting different pathophysiological pathways were examined in relation to incident AF. NT-proBNP was identified as the strongest blood-based predictor of incident AF.

EUROPACE (2023)

Article Cardiac & Cardiovascular Systems

Inclisiran and cardiovascular events: a patient-level analysis of phase III trials

Kausik K. Ray, Frederick J. Raal, David G. Kallend, Mark J. Jaros, Wolfgang Koenig, Lawrence A. Leiter, Ulf Landmesser, Gregory G. Schwartz, David Lawrence, Andrew Friedman, Lorena Garcia Conde, R. Scott Wright

Summary: Exploratory findings from the ORION trials suggest that treatment with inclisiran is associated with reductions in major cardiovascular events, providing potential cardiovascular benefits.

EUROPEAN HEART JOURNAL (2023)

Article Biochemistry & Molecular Biology

Metabolic Signatures Elucidate the Effect of Body Mass Index on Type 2 Diabetes

Qiuling Dong, Sidra Sidra, Christian Gieger, Rui Wang-Sattler, Wolfgang Rathmann, Cornelia Prehn, Jerzy Adamski, Wolfgang Koenig, Annette Peters, Harald Grallert, Sapna Sharma

Summary: Obesity is closely related to insulin resistance and diabetes, but the specific molecular mechanism that links these conditions remains unclear. This study analyzed the metabolomic profiles of a cohort of 1715 participants and found significant associations between certain metabolites and both obesity and type 2 diabetes. Further analysis suggested that lipids such as sphingomyelin and diacylphosphatidylcholine may mediate the effect of obesity on diabetes. Additionally, genetic research and experiments with mice supported the hypothesis that changes in sphingolipid and phosphatidylcholine metabolism contribute to the development of early-stage type 2 diabetes.

METABOLITES (2023)

Letter Hematology

Effect of PCSK9 Inhibition on the Plasma Proteome: A SPIRE SubStudy

Jordan M. Kraaijenhof, Tjerk S. J. Opstal, Jan H. Cornel, Dipender Gill, G. Kees Hovingh, Alberico L. Catapano, Wolfgang Koenig, Paul M. Ridker, Erik S. G. Stroes, Nick S. Nurmohamed

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2023)

Review Cardiac & Cardiovascular Systems

Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction

Nick S. Nurmohamed, Jordan M. Kraaijenhof, Manuel Mayr, Stephen J. Nicholls, Wolfgang Koenig, Alberico L. Catapano, Erik S. G. Stroes

Summary: Given the limited accuracy of clinically used risk scores, novel risk algorithms based on proteomics and lipidomics data could provide more reliable ASCVD risk prediction. Retrospective studies have consistently shown the additive prognostic value of these panels over traditional risk scores, and prospective studies are needed to determine their clinical utility.

EUROPEAN HEART JOURNAL (2023)

Article Cardiac & Cardiovascular Systems

Biomarker-based prediction of fatal and non-fatal cardiovascular outcomes in individuals with diabetes mellitus

Paul M. Haller, Alina Gossling, Christina Magnussen, Hermann Brenner, Ben Schoettker, Licia Iacoviello, Simona Costanzo, Frank Kee, Wolfgang Koenig, Allan Linneberg, Chaterina Sujana, Barbara Thorand, Veikko Salomaa, Teemu J. Niiranen, Stefan Soederberg, Henry Voelzke, Marcus Doerr, Susana Sans, Teresa Padro, Stephan B. Felix, Matthias Nauck, Astrid Petersmann, Luigi Palmieri, Chiara Donfrancesco, Roberto De Ponti, Giovanni Veronesi, Marco M. Ferrario, Kari Kuulasmaa, Tanja Zeller, Francisco M. Ojeda, Stefan Blankenberg, Dirk Westermann

Summary: This study demonstrates the role of cardiac biomarkers in predicting cardiovascular events and death in both general population and individuals with known diabetes. The findings suggest that these biomarkers can help identify individuals at highest risk for cardiovascular events and improve early identification of high-risk individuals. Therefore, they should be considered for routine risk assessment and can enhance the initiation of preventive therapies.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Retrospective real-world analysis of adherence and persistence to lipid-lowering therapy in Germany

Wolfgang Koenig, Elke S. Lorenz, Lea Beier, Ioanna Gouni-Berthold

Summary: This study investigated the real-world persistence and adherence to lipid-lowering therapies in German patients with cardiovascular disease. The findings showed low persistence and adherence rates, especially in women. The study also found that patients who discontinued treatment had a relatively short average treatment duration, and only about 10% of patients persisted in medication for more than 300 days. Overall, the persistence rates with lipid-lowering therapies were low at 36 months.

CLINICAL RESEARCH IN CARDIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Agreement among high-sensitivity cardiac troponin assays and non-invasive testing, clinical outcomes, and quality-of-care outcomes based on the 2020 European Society of Cardiology Guidelines

Julia Karady, Thomas Mayrhofer, James L. Januzzi, James E. Udelson, Jerome L. Fleg, Bela Merkely, Michael T. Lu, William F. Peacock, John T. Nagurney, Wolfgang Koenig, Maros Ferencik, Udo Hoffmann

Summary: This study aimed to determine the concordance of different high-sensitivity cardiac troponin (hs-cTn) assays in risk stratification for cardiovascular disease and compare the differences in patient management, cost, and predicted quality of care.

EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2023)

暂无数据